Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Neuroprotective effects of resident microglia following acute brain injury.
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
Episode 8 with Dr. Wendy Macklin on myelination and the zebrafish model of MS
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Episode 31 with Dr. Lloyd Kasper on the gut microbiome and MS
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Extracellular Cues Influencing Oligodendrocyte Differentiation and (Re)myelination.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Spotlight on teriflunomide.
Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Episode 10 with Dr. Richard Ransohoff on his group's latest research
Brain reserve against physical disability progression over 5 years in multiple sclerosis.
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.
Relationship between disease-modifying therapy and depression in multiple sclerosis.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
[Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis].
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS

Pages